Caroline Kistorp is a Clinical Professor at the Department of Clinical Medicine. Dr. Kistorp is affiliated with the Center of Organ and Cancer Center at Copenhagen University Hospital – Rigshospitalet as a consultant. She graduated from the University of Copenhagen as a medical doctor (MD) in 1995 and earned her PhD in 2006. He is a board-certified specialist Internal Medicine and Endocrinology.

Dr. Kistorp research is primarily focused on cardiovascular complications to endocrine disorders,  long term gonadal and cardiac complications to abusee of anabolic androgenic steroids among men and women, as well as cardiovascular and renal complications to the rare genetic disease Fabry.

Research funding obtained from (within the last 5 years):

Greater Copenhagen Research Foundation, Danish Diabetes Academy, Aase og Ejnar Danielsens Foundation, Novo Nordisk Foundation, Anti Doping Denmark

Research with commercial compagnies:

• Dr. Kistorp serve as PI in research collaboration with Sanofi Genzyme 2023-2025, and Amicus 2023-2025

Travel Grants from (within the last 5 years):

• Novo Nordisk 2021. Amicus, 2022, 2024. Sanofi Genzyme, 2023.

Speaker (fee) within the last 4-5 years)):

• Astra Zenica, 2021-2023. Boehringer Ingleheim, 2021 -2024. Novo Nordisk 2022. Chiesi 2023, Sanofi Genzyme, 2023, 2024.

• Textbook of Diabetes: Dr. Kistorp is co-author in chapter “Diabetes in hypersecreting endocrine disorders”
• Chiesi (Medicine production): Dr. Kistorp serves as ad hoc supervisor
• Sanofi Genzyme (Medicine production): Dr. Kistorp serves as ad hoc supervisor
• Amicus (medicine production) Dr. Kistorp serves as ad hoc supervisor

As a clinical professor, I hold a dual appointment, meaning that I am employed both by the Capital Region of Denmark and the University of Copenhagen. For an overview of potential conflicts of interest, please refer to my research profile in the region.